0001104659-22-097614.txt : 20220902
0001104659-22-097614.hdr.sgml : 20220902
20220902212205
ACCESSION NUMBER: 0001104659-22-097614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220901
FILED AS OF DATE: 20220902
DATE AS OF CHANGE: 20220902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOSCALZO JOSEPH
CENTRAL INDEX KEY: 0001276128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 221226677
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm2225099-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-09-01
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001276128
LOSCALZO JOSEPH
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
1
0
0
0
Stock Option (Right to Buy)
1.43
2022-09-01
4
A
0
25000
0
A
2032-08-31
Common Stock
25000
25000
D
The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.
/s/ Douglas E. Onsi as attorney-in-fact for Joseph Loscalzo
2022-09-02